| Dr Vibha S Nayak, MD | |
|
3813 Zaring Mill Cir, Louisville, KY 40241-3037 | |
| (502) 742-2970 | |
| Not Available |
| Full Name | Dr Vibha S Nayak |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 24 Years |
| Location | 3813 Zaring Mill Cir, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245443555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 39977 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Kidney Center Bluegrass, Llc | Louisville, KY | Dialysis facility |
| University Kidney Center - Broadway | Louisville, KY | Dialysis facility |
| University Of Louisville Dialysis Center, Llc | Louisville, KY | Dialysis facility |
| Jewish Hospital & St Mary's Healthcare | Louisville, KY | Hospital |
| University Of Louisville Hospital | Louisville, KY | Hospital |
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Louisville Physicians Inc | 3476725599 | 1102 |
News Archive
An estimated quarter-million former service members would have been eligible for health coverage under the joint state-federal program but their states have opted not to participate in the expansion envisioned by the federal health law. Meanwhile in Iowa, hospitals were helpful in forging a compromise on the issue.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
A multidisciplinary research team at the Johns Hopkins University School of Medicine has been awarded $8 million in funding by the National Institutes of Mental Health to develop methods to rid the body of HIV.
› Verified 3 days ago
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
An estimated quarter-million former service members would have been eligible for health coverage under the joint state-federal program but their states have opted not to participate in the expansion envisioned by the federal health law. Meanwhile in Iowa, hospitals were helpful in forging a compromise on the issue.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
A multidisciplinary research team at the Johns Hopkins University School of Medicine has been awarded $8 million in funding by the National Institutes of Mental Health to develop methods to rid the body of HIV.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vibha S Nayak, MD 3813 Zaring Mill Cir, Louisville, KY 40241-3037 Ph: (502) 742-2970 | Dr Vibha S Nayak, MD 3813 Zaring Mill Cir, Louisville, KY 40241-3037 Ph: (502) 742-2970 |
News Archive
An estimated quarter-million former service members would have been eligible for health coverage under the joint state-federal program but their states have opted not to participate in the expansion envisioned by the federal health law. Meanwhile in Iowa, hospitals were helpful in forging a compromise on the issue.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
A multidisciplinary research team at the Johns Hopkins University School of Medicine has been awarded $8 million in funding by the National Institutes of Mental Health to develop methods to rid the body of HIV.
› Verified 3 days ago
Cindy J Code, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 3950 Kresge Way, Suite 303, Louisville, KY 40207 Phone: 502-896-1880 Fax: 502-896-1887 | |
Dr. Uchenna Loretta Ozor, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 200 E Chestnut St Bldg Suite303, Louisville, KY 40202 Phone: 502-629-5552 Fax: 502-629-3132 | |
Mohamed Hegazi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 529 S Jackson St, Louisville, KY 40202 Phone: 502-562-4270 | |
Dr. Michael Patrick Krease, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1169 Eastern Pkwy Ste G58, Louisville, KY 40217 Phone: 502-452-9567 | |
Dr. Ramsey Nasri Nassar, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6400 Dutchmans Pkwy, Ste 250, Louisville, KY 40205 Phone: 502-587-9660 Fax: 502-540-5615 | |
Jeanne M Thompson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3 Audubon Plaza Dr, Ll2, Louisville, KY 40217 Phone: 502-636-8095 Fax: 502-636-8097 | |
Terrence P Donohue, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3101 Poplar Level Rd Ste 101, Louisville, KY 40213 Phone: 502-636-7444 Fax: 502-636-7112 |